ARCHIVES

Bush Limits Drug Company Efforts To Block Generics

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Prevention Program Being Developed For Primary Providers

January 29, 1988

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

NCI-Frederick Leases Office Building To Move Some Programs Off Army Base.

February 26, 2010

NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget

November 22, 1991